TZIELD™ (teplizumab-mzwv): Learn More About a Newly Approved Therapy

Learn more about the clinical safety and efficacy data for TZIELD™(teplizumab-mzwv), as well as information about the disease burden and unmet need for an approved innovative treatment.

Speaker:

Andy Cagle, MD, FAAP
Director, Field Medical Scientists, Provention Bio

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenter are those of the sponsor or presenter and not of AMCP.

Sponsored by:

Registration is free for Members and Non-Members

For individuals from the press/media who are interested in attending, please email media@amcp.org.

Register Today